Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
37.8M
-
Shares change
-
+8.35M
-
Total reported value, excl. options
-
$1.22B
-
Value change
-
+$274M
-
Put/Call ratio
-
4.29
-
Number of buys
-
88
-
Number of sells
-
-44
-
Price
-
$32.30
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2017
164 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2017.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.8M shares
of 101M outstanding shares and own 37.41% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.81M shares), BlackRock Inc. (5M shares), FMR LLC (3.34M shares), STATE STREET CORP (1.76M shares), Hillhouse Capital Management, Ltd. (1.75M shares), EcoR1 Capital, LLC (1.59M shares), JANUS HENDERSON GROUP PLC (1.41M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.12M shares), FARALLON CAPITAL MANAGEMENT LLC (1.07M shares), and JPMORGAN CHASE & CO (1.07M shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.